The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City.
BACKGROUND
The SEN virus (SENV) is a prevalent blood borne pathogen that has a worldwide incidence. SENV is comprised of eight genotypes; genotypes H and D are frequently associated with the pathogenesis of non-A - E hepatitis and post-transfusion hepatitis in blood donors and hepatitis patients. So far, no SENV pathogenesis has been reported in the liver biopsies of SENV carriers, but the frequency of SENV and its related genotypes requires further molecular epidemiology studies in different regions of the world. Occult hepatitis B infection (OBI) is another global public health problem that is primarily transmitted via blood transfusions. Therefore, the identification of OBI among blood donors is key to preventing the spread of this disease. The relationship between SENV and OBI requires further evaluation.


OBJECTIVE
The aim of this study was to determine the prevalence of SENV-D and SENV-H in blood donors in Ahvaz city with a particular focus on co-infection with OBI.


METHODS
This study had a cross-sectional design and included 184 healthy consecutive blood donors who visited a blood transfusion center in Ahvaz city from October-November 2013. The sera of all blood donors negative for HBsAg, anti-HCV antibody, and anti-HIV antibody were tested for SENV-D and SENV-H using nested polymerase chain reaction (PCR). In addition, tests for HBV DNA (PCR), HBcIgG (ELISA), liver function (aspartate transaminase and alanine transaminase), and alkaline phosphatase were carried out.


RESULTS
Liver function tests in the healthy blood donors were within the normal range. The incidence rates of SENV-D and SENV-H in the 184 total blood donors were 10 (5.4%) (95% confidence interval (CI): 2.1% - 9.0%) and 32 (17.4%) cases (95% CI: 12.0% - 23.0%), respectively. SENV-H/D co-infection occurred in 2 (1.1%) patients. The sera of 8/184 (4.3%) were positive for anti-HBc antibody but negative for HBV DNA.


CONCLUSIONS
Regardless of the presence of nonpathogenic SENV, 44/184 (24%) blood donors tested positive for both SENV-D and SENV-H. Although 4.3% of blood donors were positive for HBcIgG but negative for HBV DNA, the presence of OBI cannot be ruled out unless their liver biopsies show negative for HBV DNA.
Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran; Department of Virology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.
Samaneh
S
Abbasi
Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran; Department of Virology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.
Manoochehr
M
Makvandi
Iranian Blood Transfusion Organization (IBTO), Tehran, IR Iran.
Gharib
G
Karimi
Department of Virology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.
Niloofar
N
Neisi
Blood Donor; Chronic Hepatitis B Infection; Polymerase Chain Reaction; SEN Virus; Transfusion Transmitted Virus
J Med Virol. 2002 Sep;68(1):18-23
12210426
Transfusion. 2010 Jan;50(1):221-30
19682332
Transfusion. 2005 Jul;45(7):1084-8
15987351
Transfusion. 2009 Oct;49(10):2214-20
19527477
Turk J Gastroenterol. 2008 Jun;19(2):104-8
19110665
Curr Opin Hematol. 2011 Nov;18(6):461-6
21912252
J Infect Dis. 1991 Feb;163(2):397-9
1988524
Virus Res. 2004 Mar 15;100(2):223-8
15019240
World J Gastroenterol. 2004 Aug 15;10(16):2402-5
15285028
J Infect Dis. 1999 May;179(5):1070-6
10191206
J Gastroenterol. 2003;38(2):142-8
12640527
Arch Virol Suppl. 1992;4:116-8
1450678
J Infect Dis. 1999 Nov;180(5):1748-50
10516086
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Mar;14(1):77-9
11503032
J Hepatol. 2009 Oct;51(4):798-809
19615780
World J Gastroenterol. 2008 Jul 14;14(26):4204-8
18636667
J Infect Dis. 2003 Nov 15;188(10):1545-52
14624381
J Clin Microbiol. 2002 Sep;40(9):3140-5
12202544
Pathog Glob Health. 2014 Jul;108(5):223-8
24995918
Medscape J Med. 2008;10(12):290
19242596
J Clin Virol. 2003 May;27(1):69-73
12727531
Hepatology. 2001 May;33(5):1303-11
11343260
Lancet Infect Dis. 2002 Aug;2(8):479-86
12150847
Ann Hepatol. 2011 Apr-Jun;10(2):133-41
21502674
Antiviral Res. 2003 Sep;60(1):27-33
14516918
J Viral Hepat. 2002 Jul;9(4):243-57
12081601
J Gastroenterol Hepatol. 2009 Apr;24(4):588-98
19207682
Arch Iran Med. 2008 Jul;11(4):423-6
18588375
Nephrol Dial Transplant. 2003 Feb;18(2):348-52
12543891
World J Gastroenterol. 2014 May 28;20(20):5951-61
24876718
J Infect Dis. 2001 Aug 15;184(4):400-4
11471096
Virol J. 2010 Jan 02;7:1
20044930
Virol J. 2010 Aug 27;7:204
20799931
J Infect Dis. 2002 Feb 1;185(3):389-92
11807722